ArticleMicrobiology spectrum2025
Emergence of
Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular Epidemiology and Multilevel Drug Resistance Mechanisms ofInfection and drug resistance · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales complicate clinical management, as they are resistant to standard antibiotics and often necessitate intricate treatment plans. As a result, continuous monitoring is essential to prevent the spread of resistant strains and ensure effective treatment options are available. Enterobacterales are humans' primary contributors to urinary tract infections (UTIs). Among these, IMPORTANCE: Various antibiotic resistance and virulence genes highlight challenges in clinical management and emphasize the need for effective treatment strategies to reduce the risks associated with UTIs. Continuous research is essential to improve knowledge and create innovative approaches to tackle these urological conditions. Our study confirmed the predominance of genes related to the ST131 clone, including O25, O16, H30, and H30-Rx, among ESBL-EC. We found that the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.